Dr. Paul Janssen Award

Wed, 01 Jul 2009 16:54:00 GMT

Johnson & Johnson today announced that Axel Ullrich, Ph.D., director of the Department of Molecular Biology at the Max Planck Institute of Biochemistry in Germany, whose discoveries have led to novel cancer therapies including Herceptin® (trastuzumab)*, is the winner of the 2009 Dr. Paul Janssen Award for Biomedical Research. An independent committee of world-renowned scientists selected Dr. Ullrich, who on September 8 will receive a $100,000 prize during a ceremony in Beerse, Belgium. To view Multimedia News Release, go to http://www.prnewswire.com/mnr/pauljanssenaward/38987/

By multivu

Tags : 38987, Janssen, MultiVu, Paul, award, biomedical, disease, genomics, molecular, research

PERSONALIZED MEDICINE FOR LUNG CANCER OFFERS MORE EFFECTIVE TREATMENT FOR PATIENTS

Sat, 15 Nov 2008 09:43:02 GMT

With more than 215,000 Americans estimated to be diagnosed with lung cancer in 2008, Moffitt Cancer Center is doing its part to fight this disease by launching an awareness and education initiative addressing the facts surrounding lung cancer and showcasing how personalized medicine treatment techniques are breaking new ground for those diagnosed. To view Multimedia News Release, go to http://www.prnewswire.com/mnr/moffittcancercenter/35943/

By multivu

Tags : 35943, cancer, center, lung, medicine, moffitt, molecular, multivu, patients, personalized, therapy, treatment

Viddler > All tags- molecular for multivu

Dr. Paul Janssen Award

PERSONALIZED MEDICINE FOR LUNG CANCER OFFERS MORE EFFECTIVE TREATMENT FOR PATIENTS